C3Nano Refutes Cambrios’ Claims of Patent Invalidity

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
32
C3Nano Refutes Cambrios’ Claims of Patent Invalidity

HAYWARD, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) -- C3Nano Inc. , the world’s performance leader in transparent conductive inks and films used in flexible displays, touchscreens and other products refutes the claims made by China-based Cambrios in its attempt to initiate an inter partes review (IPR) related to the validity of one of C3Nano’s United States patents. Since inception in 2010, C3Nano has conducted R&D in the chemical fusing of conductive nanostructures , and is widely recognized by leading global customers as the first company to successfully develop a commercially viable and scalable transparent conductor based on nanoscale metallic fused conductors, with performance exceeding that of all other competitive technologies.  Cambrios is a subsidiary of CAM Holding Co., British Virgin Islands, a related party of TPK Holding Co., Ltd in China.

C3Nano has a large number of core patents protecting its commercial products including inks and films, as well as customers’ devices. The subject patent, number 9,183,968, is related to C3Nano’s unique technology based on fusing nanomaterials. 

“C3Nano will enforce its patents to protect its valuable proprietary technology, which has resulted in superior products,” said Cliff Morris, CEO of C3Nano.  “Preemptive attacks by Cambrios or other patent infringers will not thwart these efforts.” 

Background Recently, C3Nano has won several key business opportunities over Cambrios/CAM Holding Co. Ltd. and other competitors due to the superior performance of C3Nano products. C3Nano has observed increased media campaigns, including frivolous intellectual property claims, by competitors attempting to detract from C3Nano’s gain in worldwide market share.  It is well known in the industry that C3Nano’s unique and proprietary technology, NanoGlue™, is the critical enabler of the fusing of nanowires to alleviate junction resistance and create the superior performance needed for foldable devices and Tier 1 applications such as smart phones and tablets. The science and engineering behind NanoGlue have been validated globally by multiple customers as well as independent experts.

Cambrios, originally Cambrios Technologies Corporation, was an MIT spin-off that went into insolvency in 2016.  Public information indicates that over 80 million USD in equity had been invested and possibly lost by multiple U.S. and international investors. The company was liquidated with the assets auctioned off and purchased by Champ Great International Corporation, an entity whose name veils its connection to TPK Holding Co., Ltd. in China.

As a reincarnated Cambrios tries to restart its business under new Chinese ownership and management, it has sought quick monetization of the patents acquired from the defunct U.S. company. In comparison, C3Nano has benefited from stable management and R&D talent to advance its technology multiple generations ahead of competitors, and has industriously focused on commercialization of its technology to deliver the best performance and value to customers. 

Recent patent-related action by Cambrios represents ongoing fallout from the May 2018  Society for Information Display (SID) conference in Los Angeles, when Cambrios’ lead scientist presented data that raised questions among industry players of Cambrios’ possible infringement of C3Nano’s fusing IP. 

C3Nano began as a four-person startup, spun off from Stanford University. C3Nano is well known in the industry for its high ethical standards, respect of IP, and research and development philosophy that do not violate any known valid IP. C3Nano has strong customer loyalty because of its leading product performance and technical support. C3Nano will enforce its patents to protect its valuable proprietary technology and superior products. 

About C3Nano, Inc.

Founded in 2010 as a spinout from Stanford University, C3Nano is an advanced materials company focused on developing new materials and chemistries for a wide range of electronic applications. C3Nano’s investors and partners include GSR Ventures, Nissha Printing Co., Ltd., Phoenix Venture Partners, Hitachi Chemical, Lens Technology, Nagase America, and several undisclosed investors, including a top global mobile and internet technology company headquartered in Silicon Valley.

Contact Kevin Gallagher Gallagher PR +1 (510) 599-0416 kevin@gallagherpr.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...e26eca63c8

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI-Driven Software Growth Faces Profitability Hurdles

Updated Category News Views 153

AI and Growth: A Tale of Two Strategies Is AI the superhero we’ve been waiting for, or just another fad? The KeyBanc Capital Markets' 2026 AI x Software Benchmark throws more questions into the ring than it answers. This benchmark isn't just numbers on a page; it's a pulse check on how AI is reshaping the software landscape. Seeing AI-native firms grow at a dizzying 34%...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 130

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 98

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 227

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 148

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 73

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 85

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 126

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming a Small Investment in Royal Caribbean Into Wealth

Updated Category News Views 156

The Power of Long-Term Investing in Royal Caribbean Investing in the stock market can often seem intimidating, especially for newcomers. However, a closer look at companies like Royal Caribbean Gr (NASDAQ: RCL) demonstrates the potential rewards of disciplined investing over time. Having shown remarkable performance, Royal Caribbean has an annualized return that exceeds...

Continue Reading
Immuron's Financial Growth and Clinical Progress Update

Updated Category News Views 149

Immuron's Consistent Growth and Exciting Projects Update Immuron Limited, a biopharmaceutical company based in Australia and publicly traded on the NASDAQ under the ticker IMRN and ASX ticker IMC.AX, is announcing some significant updates that reflect its ongoing commitment to healthcare innovation. The company's recent sales figures and progress in clinical trials...

Continue Reading
General Motors Growth Potential: Insights from Analysts

Updated Category News Views 281

General Motors Gets a Boost from Analysts In recent developments, General Motors Company (NYSE: GM) has garnered notable attention from financial analysts, particularly following Barclays' upgrade of the stock. The analysts play a vital role in assessing the market potential for stocks, and their insights can greatly influence investor confidence. Analyst Upgrades Impact...

Continue Reading
BioAge Labs Faces Class Action Lawsuit: Deadline Approaches Soon

Updated Category News Views 314

BioAge Labs Faces Class Action Lawsuit Investors of BioAge Labs, Inc. (NASDAQ: BIOA) are currently navigating a challenging landscape as a class action lawsuit is underway against the biopharmaceutical company. This underscores the importance for shareholders to stay informed about the developments following the company's recent stock performance and ensuing legal...

Continue Reading
Audit BEE Celebrates Dual Honors at Global Brand Awards

Updated Category News Views 177

Audit BEE Wins Prestigious Global Brand Awards Audit BEE has achieved remarkable recognition for its Excellence in Compliance and Advisory Leadership, recently celebrated at the prestigious Global Brand Awards. These awards, organized by Global Brands Magazine, acknowledge outstanding contributions from brands worldwide, showing the importance of excellence across various...

Continue Reading